These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inhibition of influenza A virus by mixed siRNAs, targeting the PA, NP, and NS genes, delivered by hybrid microcarriers. Brodskaia AV; Timin AS; Gorshkov AN; Muslimov AR; Bondarenko AB; Tarakanchikova YV; Zabrodskaya YA; Baranovskaya IL; Il'inskaja EV; Sakhenberg EI; Sukhorukov GB; Vasin AV Antiviral Res; 2018 Oct; 158():147-160. PubMed ID: 30092251 [TBL] [Abstract][Full Text] [Related]
3. Interaction of Host Nucleolin with Influenza A Virus Nucleoprotein in the Early Phase of Infection Limits the Late Viral Gene Expression. Kumar D; Broor S; Rajala MS PLoS One; 2016; 11(10):e0164146. PubMed ID: 27711134 [TBL] [Abstract][Full Text] [Related]
4. Effective small interfering RNAs targeting matrix and nucleocapsid protein gene inhibit influenza A virus replication in cells and mice. Zhou H; Jin M; Yu Z; Xu X; Peng Y; Wu H; Liu J; Liu H; Cao S; Chen H Antiviral Res; 2007 Nov; 76(2):186-93. PubMed ID: 17719657 [TBL] [Abstract][Full Text] [Related]
5. Expression of a single siRNA against a conserved region of NP gene strongly inhibits in vitro replication of different Influenza A virus strains of avian and swine origin. Stoppani E; Bassi I; Dotti S; Lizier M; Ferrari M; Lucchini F Antiviral Res; 2015 Aug; 120():16-22. PubMed ID: 25986248 [TBL] [Abstract][Full Text] [Related]
6. Phospholipid scramblase 1 interacts with influenza A virus NP, impairing its nuclear import and thereby suppressing virus replication. Luo W; Zhang J; Liang L; Wang G; Li Q; Zhu P; Zhou Y; Li J; Zhao Y; Sun N; Huang S; Zhou C; Chang Y; Cui P; Chen P; Jiang Y; Deng G; Bu Z; Li C; Jiang L; Chen H PLoS Pathog; 2018 Jan; 14(1):e1006851. PubMed ID: 29352288 [TBL] [Abstract][Full Text] [Related]
7. siRNAs targeting PB2 and NP genes potentially inhibit replication of Highly Pathogenic H5N1 Avian Influenza Virus. Behera P; Nagarajan S; Murugkar HV; Kalaiyarasu S; Prakash A; Gothalwal R; Dubey SC; Kulkarni DD; Tosh C J Biosci; 2015 Jun; 40(2):233-40. PubMed ID: 25963253 [TBL] [Abstract][Full Text] [Related]
8. Antiviral activity of a synthesized shikonin ester against influenza A (H1N1) virus and insights into its mechanism. Zhang Y; Han H; Qiu H; Lin H; Yu L; Zhu W; Qi J; Yang R; Pang Y; Wang X; Lu G; Yang Y Biomed Pharmacother; 2017 Sep; 93():636-645. PubMed ID: 28688289 [TBL] [Abstract][Full Text] [Related]
9. Transportan-derived cell-penetrating peptide delivers siRNA to inhibit replication of influenza virus in vivo. Zhang C; Ren W; Liu Q; Tan Z; Li J; Tong C Drug Des Devel Ther; 2019; 13():1059-1068. PubMed ID: 31040643 [TBL] [Abstract][Full Text] [Related]
10. Discovery of a Novel Specific Inhibitor Targeting Influenza A Virus Nucleoprotein with Pleiotropic Inhibitory Effects on Various Steps of the Viral Life Cycle. Yang F; Pang B; Lai KK; Cheung NN; Dai J; Zhang W; Zhang J; Chan KH; Chen H; Sze KH; Zhang H; Hao Q; Yang D; Yuen KY; Kao RY J Virol; 2021 Apr; 95(9):. PubMed ID: 33627391 [TBL] [Abstract][Full Text] [Related]
11. Antiviral activity of SA-2 against influenza A virus in vitro/vivo and its inhibition of RNA polymerase. Yu J; Wang D; Jin J; Xu J; Li M; Wang H; Dou J; Zhou C Antiviral Res; 2016 Mar; 127():68-78. PubMed ID: 26802558 [TBL] [Abstract][Full Text] [Related]
12. Knockdown of FLT4, Nup98, and Nup205 Cellular Genes Effectively Suppresses the Reproduction of Influenza Virus Strain A/WSN/1933 (H1N1) In vitro. Pashkov E; Korchevaya E; Faizuloev E; Rtishchev A; Cherepovich B; Bystritskaya E; Sidorov A; Poddubikov A; Bykov A; Dronina Y; Svitich O; Zverev V Infect Disord Drug Targets; 2022; 22(5):e250322202629. PubMed ID: 35339191 [TBL] [Abstract][Full Text] [Related]
13. TRIM41-Mediated Ubiquitination of Nucleoprotein Limits Influenza A Virus Infection. Patil G; Zhao M; Song K; Hao W; Bouchereau D; Wang L; Li S J Virol; 2018 Aug; 92(16):. PubMed ID: 29899090 [TBL] [Abstract][Full Text] [Related]
14. Nucleotide resolution mapping of influenza A virus nucleoprotein-RNA interactions reveals RNA features required for replication. Williams GD; Townsend D; Wylie KM; Kim PJ; Amarasinghe GK; Kutluay SB; Boon ACM Nat Commun; 2018 Jan; 9(1):465. PubMed ID: 29386621 [TBL] [Abstract][Full Text] [Related]
15. Sumoylation of influenza A virus nucleoprotein is essential for intracellular trafficking and virus growth. Han Q; Chang C; Li L; Klenk C; Cheng J; Chen Y; Xia N; Shu Y; Chen Z; Gabriel G; Sun B; Xu K J Virol; 2014 Aug; 88(16):9379-90. PubMed ID: 24920808 [TBL] [Abstract][Full Text] [Related]
16. [Antiviral effect of «Kagocel» substance in vitro on influenza viruses H1N1, H1N1pdm09 and H3N2.]. Fediakina IT; Konopleva MV; Proshina ES; Linnik EV; Nikitina NI Vopr Virusol; 2019; 64(3):125-131. PubMed ID: 31622059 [TBL] [Abstract][Full Text] [Related]
17. Structure-based discovery of the novel antiviral properties of naproxen against the nucleoprotein of influenza A virus. Lejal N; Tarus B; Bouguyon E; Chenavas S; Bertho N; Delmas B; Ruigrok RW; Di Primo C; Slama-Schwok A Antimicrob Agents Chemother; 2013 May; 57(5):2231-42. PubMed ID: 23459490 [TBL] [Abstract][Full Text] [Related]
18. Host- and strain-specific regulation of influenza virus polymerase activity by interacting cellular proteins. Bortz E; Westera L; Maamary J; Steel J; Albrecht RA; Manicassamy B; Chase G; Martínez-Sobrido L; Schwemmle M; García-Sastre A mBio; 2011; 2(4):. PubMed ID: 21846828 [TBL] [Abstract][Full Text] [Related]